Real-time enrollment status for this covid-19 clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT05074420 |
| Recruiting Status | Terminated |
| Condition | COVID-19 |
| Phase | Clinical Trial |
| Target Enrollment | 24 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | December 17, 2025 (Dec 17, 2025) |
As of March 2, 2026: Clinical trial NCT05074420 is currently terminated participants. This clinical trial study for covid-19 is not currently accepting new participants at 3 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05074420 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05074420 was last updated Dec 17, 2025 (December 17, 2025). HelloStudys verifies this status automatically.